Based on the recognized role of TNF in autoimmune disorders, since 1988 different drugs targeting TNF signaling have been successfully introduced for the treatment of inflammatory disease such as rheumatoid arthritis, inflammatory bowel disease, Crohn’s disease and ankylosing spondylitis, psoriasis [186,187,188]. Here, TNF is linked to ankylosing spondylitis.